• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物组与心血管疾病。

Microbiome and Cardiovascular Disease.

机构信息

Departments of Internal and Experimental Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Handb Exp Pharmacol. 2022;270:311-334. doi: 10.1007/164_2020_356.

DOI:10.1007/164_2020_356
PMID:32185503
Abstract

Atherosclerotic cardiovascular disease (ASCVD) is a prime example of a systems disease. In the initial phase, apolipoprotein B-containing cholesterol-rich lipoproteins deposit excess cholesterol in macrophage-like cells that subsequently develop into foam cells. A multitude of systemic as well as environmental factors are involved in further progression of atherosclerotic plaque formation. In recent years, both oral and gut microbiota have been proposed to play an important role in the process at different stages. Particularly bacteria from the oral cavity may easily reach the circulation and cause low-grade inflammation, a recognized risk factor for ASCVD. Gut-derived microbiota on the other hand can influence host metabolism on various levels. Next to translocation across the intestinal wall, these prokaryotes produce a great number of specific metabolites such as trimethylamine and short-chain fatty acids but can also metabolize endogenously formed bile acids and convert these into metabolites that may influence signal transduction pathways. In this overview, we critically discuss the novel developments in this rapidly emerging research field.

摘要

动脉粥样硬化性心血管疾病(ASCVD)是系统疾病的一个主要例子。在初始阶段,载脂蛋白 B 含有的富含胆固醇的脂蛋白会将多余的胆固醇沉积在类似于巨噬细胞的细胞中,这些细胞随后会发展成泡沫细胞。多种系统性和环境因素都参与了动脉粥样硬化斑块形成的进一步进展。近年来,口腔和肠道微生物群都被认为在不同阶段的过程中发挥着重要作用。特别是口腔中的细菌可能很容易进入循环系统并引起低度炎症,这是 ASCVD 的一个公认的危险因素。另一方面,肠道来源的微生物群可以在多个层面上影响宿主的新陈代谢。除了穿过肠壁的易位外,这些原核生物还产生了大量的特定代谢物,如三甲胺和短链脂肪酸,但也可以代谢内源性形成的胆汁酸,并将其转化为可能影响信号转导途径的代谢物。在这篇综述中,我们批判性地讨论了这一快速发展的研究领域的新进展。

相似文献

1
Microbiome and Cardiovascular Disease.微生物组与心血管疾病。
Handb Exp Pharmacol. 2022;270:311-334. doi: 10.1007/164_2020_356.
2
Microbiome and Cardiovascular Disease微生物群与心血管疾病
3
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.连接免疫系统、系统性慢性炎症和肠道微生物组:性别的作用。
J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1.
4
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.肠道微生物群在动脉粥样硬化性心血管疾病发展中的作用。
Int J Mol Sci. 2023 Mar 12;24(6):5420. doi: 10.3390/ijms24065420.
5
Gut Microbiota and Cardiovascular Disease.肠道微生物群与心血管疾病。
Circ Res. 2020 Jul 31;127(4):553-570. doi: 10.1161/CIRCRESAHA.120.316242. Epub 2020 Jul 30.
6
Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?肠道微生物群与代谢产物,动脉粥样硬化诊断与治疗的未来方向?
Pharmacol Res. 2023 Jan;187:106586. doi: 10.1016/j.phrs.2022.106586. Epub 2022 Nov 30.
7
Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases.肠道微生物对胆汁酸组成的调节在心血管疾病发病机制中的新作用。
Nutrients. 2023 Apr 12;15(8):1850. doi: 10.3390/nu15081850.
8
Update on gut microbiota in cardiovascular diseases.心血管疾病中肠道微生物组的最新研究进展。
Front Cell Infect Microbiol. 2022 Nov 10;12:1059349. doi: 10.3389/fcimb.2022.1059349. eCollection 2022.
9
Molecular interactions between the intestinal microbiota and the host.肠道微生物群与宿主之间的分子相互作用。
Mol Microbiol. 2022 Jun;117(6):1297-1307. doi: 10.1111/mmi.14905. Epub 2022 Apr 25.
10
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.白藜芦醇通过重塑肠道微生物群调节氧化三甲胺(TMAO)合成和胆汁酸代谢,减轻TMAO诱导的动脉粥样硬化。
mBio. 2016 Apr 5;7(2):e02210-15. doi: 10.1128/mBio.02210-15.

引用本文的文献

1
Gut microbiota and ovarian diseases: a new therapeutic perspective.肠道微生物群与卵巢疾病:一种新的治疗视角。
J Ovarian Res. 2025 May 21;18(1):105. doi: 10.1186/s13048-025-01684-5.
2
Differential Oral Microbiota and Serum Cytokine Signatures in Age-Grouped Patients with Marfan Syndrome.马方综合征患者按年龄分组的口腔微生物群和血清细胞因子特征差异
Biomedicines. 2025 Jan 31;13(2):330. doi: 10.3390/biomedicines13020330.
3
Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy.

本文引用的文献

1
Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial.治疗心肌梗死患者的牙周病:一项随机临床试验。
Eur J Intern Med. 2020 Jan;71:76-80. doi: 10.1016/j.ejim.2019.08.012. Epub 2019 Dec 4.
2
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction.三甲胺 N-氧化物结合并激活 PERK 以促进代谢功能障碍。
Cell Metab. 2019 Dec 3;30(6):1141-1151.e5. doi: 10.1016/j.cmet.2019.08.021. Epub 2019 Sep 19.
3
The intestinal microbiota fuelling metabolic inflammation.肠道微生物群促进代谢性炎症。
深入了解肠道菌群失调介导的黏膜免疫在 IgA 肾病中的作用。
BMC Nephrol. 2024 Jun 21;25(1):203. doi: 10.1186/s12882-024-03646-3.
4
Another Look at the Contribution of Oral Microbiota to the Pathogenesis of Rheumatoid Arthritis: A Narrative Review.重新审视口腔微生物群在类风湿关节炎发病机制中的作用:一项叙述性综述
Microorganisms. 2021 Dec 28;10(1):59. doi: 10.3390/microorganisms10010059.
5
The influence of gut microbiota in cardiovascular diseases-a brief review.肠道微生物群在心血管疾病中的影响——简要综述
Porto Biomed J. 2021 Jan 18;6(1):e106. doi: 10.1097/j.pbj.0000000000000106. eCollection 2021 Jan-Feb.
6
A Novel Insight at Atherogenesis: The Role of Microbiome.动脉粥样硬化形成的新见解:微生物群的作用。
Front Cell Dev Biol. 2020 Sep 22;8:586189. doi: 10.3389/fcell.2020.586189. eCollection 2020.
Nat Rev Immunol. 2020 Jan;20(1):40-54. doi: 10.1038/s41577-019-0198-4. Epub 2019 Aug 6.
4
Duration and life-stage of antibiotic use and risk of cardiovascular events in women.抗生素使用时长和阶段与女性心血管事件风险的相关性。
Eur Heart J. 2019 Dec 14;40(47):3838-3845. doi: 10.1093/eurheartj/ehz231.
5
Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model.噬菌体对小鼠模型肠道微生物群和代谢组的动态调节。
Cell Host Microbe. 2019 Jun 12;25(6):803-814.e5. doi: 10.1016/j.chom.2019.05.001. Epub 2019 Jun 4.
6
Metabolomic Pattern Predicts Incident Coronary Heart Disease.代谢组学模式预测冠心病事件。
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1475-1482. doi: 10.1161/ATVBAHA.118.312236. Epub 2019 May 16.
7
Alterations in the gut microbiome and metabolism with coronary artery disease severity.肠道微生物组和代谢与冠状动脉疾病严重程度的改变。
Microbiome. 2019 Apr 26;7(1):68. doi: 10.1186/s40168-019-0683-9.
8
Bile Acids as Metabolic Regulators and Nutrient Sensors.胆汁酸作为代谢调节剂和营养传感器。
Annu Rev Nutr. 2019 Aug 21;39:175-200. doi: 10.1146/annurev-nutr-082018-124344. Epub 2019 Apr 24.
9
Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.肠道微生物与心血管表型和风险相关的血浆代谢物的关联。
Circ Res. 2019 Jun 7;124(12):1808-1820. doi: 10.1161/CIRCRESAHA.118.314642. Epub 2019 Apr 11.
10
Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.噬菌体触发抗病毒免疫,防止细菌感染清除。
Science. 2019 Mar 29;363(6434). doi: 10.1126/science.aat9691.